Second deal for Bain Capital

The US private equity firm has made its second carve-out acquisition in three days with the E200m purchase of Trespaphan from Celanese.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.